DSpace at RU >

Search Results

Results 1-17 of 17.

Item hits:

Full Text	Issue Date	Title	Author(s)
	2010	Phase I evaluation of cediranib, a selective VEGFR signalling inhibitor, in combination with gefitinib in patients with advanced tumours.	Cruijsen, H. van; Voest, E.E.; Punt, C.J.A.; Hoekman, K.; Witteveen, P.O.; Meijerink, M.R.; Puchalski, T.A.; Robertson, J.; Saunders, O.; Jurgensmeier, J.M.; Herpen, C.M.L. van; Giaccone, G.
	2009	Effective strategies for management of hypertension after vascular endothelial growth factor signaling inhibition therapy: results from a phase II randomized, factorial, double-blind study of Cediranib in patients with advanced solid tumors.	Langenberg, M.H.; Herpen, C.M.L. van; Bono, J. De; Schellens, J.H.; Unger, C.; Hoekman, K.; Blum, H.E.; Fiedler, W.; Drevs, J.; Maulf, F. Le; Fielding, A.; Robertson, J.; Voest, E.E.
	2009	Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer.	Tol, J.; Koopman, M.; Cats, A.; Rodenburg, C.J.; Creemers, G.J.; Schrama, J.G.; Erdkamp, F.L.; Vos, A.H.; Groeningen, C.J. van; Sinnige, H.A.M.; Richel, D.J.; Voest, E.E.; Dijkstra, J.R.; Vink-Borger, M.E.; Antonini, N.F.; Mol, L.; Krieken, J.H.J.M. van; Dalesio, O.; Punt, C.J.A.
	2008	Allele-specific regulation of primary cilia function by the von Hippel-Lindau tumor suppressor	Lolkema, M.P.; Mans, D.A.; Ulfman, L.H.; Volpi, S.; Voest, E.E.; Giles, R.H.
	2008	Factors influencing catheter-related infections in the Dutch multicenter study on high-dose chemotherapy followed by peripheral SCT in high-risk breast cancer patients.	Nieboer, P.; Vries, E.G. de; Mulder, N.H.; Rodenhuis, S.; Bontenbal, M.; Wall, E. van der; Hoesel, Q.G.C.M. van; Smit, W.M.; Hupperets, P.; Voest, E.E.; Nooij, M.A.; Boezen, H.M.; Graaf, W.T.A. van der
	2008	[Angiogenesis inhibitors for the systemic treatment of metastatic renal cell carcinoma: sunitinib, sorafenib, bevacizumab and temsirolimus]	Mulder, P.H.M. de; Haanen, J.B.; Sleijfer, S.; Kruit, W.H.; Gietema, J.A.; Richel, D.J.; Groenewegen, G.; Voest, E.E.; Eertwegh, A.J. van den; Osanto, S.; Jansen, R.L.; Mulders, P.F.A.
	2008	All along the watchtower: is the cilium a tumor suppressor organelle?	Mans, D.A.; Voest, E.E.; Giles, R.H.
	2008	Mobility of the von Hippel-Lindau tumour suppressor protein is regulated by kinesin-2.	Mans, D.A.; Lolkema, M.P.; Beest, M van; Daenen, L.G.; Voest, E.E.; Giles, R.H.
	2006	Interleukin-8 CSF levels predict survival in patients with leptomeningeal metastases.	Brandsma, D.; Taphoorn, M.J.B.; Jager, W. de; Bonfrer, H.; Algra, A.; Reijneveld, J.C.; Boogerd, W.; Korse, T.; Verbeek, M.M.; Rijkers, G.T.; Voest, E.E.
	2006	Interplay between VHL/HIF1alpha and Wnt/beta-catenin pathways during colorectal tumorigenesis.	Giles, R.H.; Lolkema, M.P.; Snijckers, C.M.; Belderbos, M.; Groep, P. van der; Mans, D.A.; Beest, M. van; Noort, M. van; Goldschmeding, R.; Diest, P.J. van; Clevers, H.; Voest, E.E.
	2006	CSF protein profiling using Multiplex Immuno-assay : A potential new diagnostic tool for leptomeningeal metastases.	Brandsma, D.; Voest, E.E.; Jager, W. de; Bonfrer, H.; Algra, A.; Boogerd, W.; Korse, T.; Reijneveld, J.C.; Verbeek, M.M.; Rijkers, G.; Taphoorn, M.J.B.
	2005	CSF levels of angiogenesis-related proteins in patients with leptomeningeal metastases.	Reijneveld, J.C.; Brandsma, D.; Boogerd, W.; Bonfrer, J.G.; Kalmijn, S.; Voest, E.E.; Geurts-Moespot, A.; Visser, M.C.; Taphoorn, M.J.B.
	2005	Fatigue and relating factors in high-risk breast cancer patients treated with adjuvant standard or high-dose chemotherapy: a longitudinal study.	Nieboer, P.; Buijs, C.; Rodenhuis, S.; Seynaeve, C.; Beex, L.V.A.M.; Wall, E. van der; Richel, D.J.; Nooij, M.A.; Voest, E.E.; Hupperets, P.S.G.J.; Mulder, N.H.; Graaf, W.T.A. van der; Vergert, E.M. ten; Tinteren, H.L.G. van; Vries, E.G.F. de
	2004	Fibronectin is a hypoxia-independent target of the tumor suppressor VHL.	Bluyssen, H.A.; Lolkema, M.P.; Beest, M. van; Boone, M.; Snijckers, C.M.; Los, M.; Gebbink, M.F.; Braam, B.; Holstege, F.C.; Giles, R.H.; Voest, E.E.
	2004	The von Hippel-Lindau tumor suppressor protein influences microtubule dynamics at the cell periphery.	Lolkema, M.P.; Mehra, N.; Jorna, A.S.; Beest, M. van; Giles, R.H.; Voest, E.E.
	2002	Reduced tumor growth, experimental metastasis information, and angiogenesis in rats with a hyperreactive dopaminergic system	Teunis, M.A.T.; Kavelaars, A.M.A.A.; Voest, E.E.; Bakker, J.M.; Ellenbroek, B.A.; Cools, A.R.; Heijnen, C.J.
	1997	Phase IB study of doxorubicin in combination with the multidrug resistance reversing agent S9788 in advanced colorectal and renal cell cancer	Punt, C.J.A.; Voest, E.E.; Tueni, E.; Oosterom, A. van; Backx, A.P.C.M.; Mulder, P.H.M. de; Hecquet, B.; Lucas, C.; Gerard, B.; Bleiberg, H.

1